Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica D Mead

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Bone Marrow Transplantation|November 10, 2020
Axicabtagene Ciloleucel CAR T-cell therapy for relapsed/refractory secondary CNS non-Hodgkin lymphoma: comparable outcomes and toxicities, but shorter remissions may warrant alternative consolidative strategies?Sanaz Ghafouri, John Timmerman, Sarah Larson, et al.
American Family Physician|May 3, 2014
Leukemia: an overview for primary careAmanda S Davis, Anthony J Viera, Monica D Mead
Lancet (London, England)|August 7, 2022
Immune tolerance induction through haematopoietic chimerism after kidney donationNima Nassiri, Erik Lum, Monica D Mead, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Bone Marrow Transplantation|November 10, 2020
Axicabtagene Ciloleucel CAR T-cell therapy for relapsed/refractory secondary CNS non-Hodgkin lymphoma: comparable outcomes and toxicities, but shorter remissions may warrant alternative consolidative strategies?Sanaz Ghafouri, John Timmerman, Sarah Larson, et al.
American Family Physician|May 3, 2014
Leukemia: an overview for primary careAmanda S Davis, Anthony J Viera, Monica D Mead
Lancet (London, England)|August 7, 2022
Immune tolerance induction through haematopoietic chimerism after kidney donationNima Nassiri, Erik Lum, Monica D Mead, et al.
Pageof 1